Cargando…
Assessment of treatment response in chronic constipation clinical trials
BACKGROUND: While chronic constipation (CC) clinical trials have focused primarily on bowel symptoms (symptoms directly related to bowel movements), abdominal symptoms are also prevalent among patients. The United States Food and Drug Administration’s (FDA’s) guidance on the use of patient-reported...
Autores principales: | Ervin, Claire M, Fehnel, Sheri E, Baird, Mollie J, Carson, Robyn T, Johnston, Jeffrey M, Shiff, Steven J, Kurtz, Caroline B, Mangel, Allen W |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4051515/ https://www.ncbi.nlm.nih.gov/pubmed/24940076 http://dx.doi.org/10.2147/CEG.S58321 |
Ejemplares similares
-
Psychometric validation of patient-reported outcome measures assessing chronic constipation
por: Nelson, Lauren M, et al.
Publicado: (2014) -
Urgency as an Endpoint in Irritable Bowel Syndrome
por: Mangel, Allen W., et al.
Publicado: (2011) -
Linaclotide in Chronic Idiopathic Constipation Patients with Moderate to Severe Abdominal Bloating: A Randomized, Controlled Trial
por: Lacy, Brian E., et al.
Publicado: (2015) -
Exploring the Diabetic Gastroparesis Patient Experience: Patient Exit Interviews
por: Ervin, Claire M., et al.
Publicado: (2017) -
The impact of abdominal pain on global measures in patients with chronic idiopathic constipation, before and after treatment with linaclotide: a pooled analysis of two randomised, double-blind, placebo-controlled, phase 3 trials
por: Chang, L, et al.
Publicado: (2014)